HEALTHCARE & MEDICARE
-
Ionis Pharma's Rare Disease Drugs Not Approved Therapy Meets Critical Research Targets
Patients with specific genetic disorders whose symptoms include a progressively worsening muscle control can walk faster after experimental Ionis Pharmaceuticals…
Read More » -
Promote, not information, for participation and adoption
You have groundbreaking medical devices or digital health applications and data to show improved health outcomes or lower costs. You…
Read More » -
New bereavement cost calculator shows that sadness is expensive – Healthcare Blog
Emma Payne Sadness is expensive. In addition to major human impacts, studies have shown that bereavement leads to a 20%-30%…
Read More » -
AI hallucinations: What are they, always terrible?
Hallucinations are a regular focus of conversations about healthcare AI. But what do they actually mean in practice? This is…
Read More » -
Pfizer's $4.9B Metsera acquisition makes it a major player in obesity drugs and more people
Pfizer's internal obesity drug development stumbled upon, but the drug giant passed a billion-dollar acquisition of the multi-billion-dollar clinical-stage company…
Read More » -
Pharmacology can help buffer female heart disease patients from cutting funding
Coronary artery disease is one of the most important causes of death among American women. It is every third of…
Read More » -
The seven or eight-year-old raised $8 million to expand access to maternal mental health support
It announced Thursday that seven virtual women’s behavioral health companies, Starling, have received $8 million in funding to help expand…
Read More » -
The seven or eight-year-old raised $8 million to expand access to maternal mental health support
It announced Thursday that seven virtual women’s behavioral health companies, Starling, have received $8 million in funding to help expand…
Read More » -
The lawyer said
AI Agents – autonomous, task-specific systems designed to perform functions with little to no human intervention – gained traction in…
Read More » -
For many people, the car T is a miracle therapy – we need to give it to more patients
The U.S. Food and Drug Administration (FDA) recently removed its Risk Assessment and Mitigation Strategies (REMS) from automotive immunotherapy. REMS…
Read More »